Modeling Human Genetic Disorders with CRISPR Technologies in Xenopus

Helen Rankin Willsey1, Matthew Guille2, Robert M Grainger3

  • 1Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143, USA; helen.willsey@ucsf.edu rmg9p@virginia.edu.

Cold Spring Harbor Protocols
|September 17, 2021
PubMed
Summary

This study presents a pipeline combining Xenopus developmental biology and CRISPR technology to understand human genetic disorders. It enables functional insights into disease-related genes for potential therapeutic development.